介入再通配合活血化瘀中药治疗输卵管阻塞性不孕症的前瞻性研究

目的研究介入再通配合活血化瘀中药对输卵管阻塞性不孕症的治疗效果。方法前瞻性研究经子宫输卵管造影(HSG)检查证实为输卵管近段完全阻塞511例,随机分为试验组和对照组,两组均经输卵管介入再通术疏通阻塞输卵管,试验组术中术后加活血化瘀中药治疗,对照组为经典介入再通术,不予中药治疗。失访病例72例,实际纳入研究病例439例。经12个月和24个月随访,评价输卵管通畅度、宫内妊娠率和输卵管妊娠率。结果介入后12个月和24个月,试验组的输卵管完全通畅率明显高于对照组,再闭塞率及通而不畅率显著低于对照组;输卵管妊娠率显著低于对照组。结论介入再通配合活血化瘀中药治疗输卵管阻塞性不孕具有良好的临床疗效。     

选择性输卵管造影与再通术结合中西药治疗阻塞性不孕的探讨

目的探讨输卵管插管造影与再通术结合中西药治疗输卵管阻塞性不孕的效果.方法对不孕妇女排除男女不孕因素及女方功能性不孕后,经宫颈常规行子宫、输卵管造影(HSG),对显示双侧输卵管阻塞的9例妇女,采用选择性插管至输卵管开口处,推注30%泛影葡胺造影剂,对证实阻塞者行导丝再通,其中43例再通术后,中西药治疗1～4个月;40例对照组插管再通术后单服抗生素治疗4～6天,术后均随访1～4个月,6例未随访,观察两组受孕率.结果插管成功率100%,无严重并发症,复通率80%,再通术后未行中药治疗组妊娠率27.5%(11/40),再通术后中西药治疗组妊娠率60%(26/43).结论选择性输卵管造影与插管再通术,术后配合活血化瘀,消炎解毒的中西药治疗是目前治疗输卵管近、中段阻塞性不孕的最好方法.     

选择性输卵管造影与再通术结合中西药治疗阻塞性不孕的探讨

目的　探讨输卵管插管造影与再通术结合中西药治疗输卵管阻塞性不孕的效果 .方法　对不孕妇女排除男女不孕因素及女方功能性不孕后 ,经宫颈常规行子宫、输卵管造影 (HSG) ,对显示双侧输卵管阻塞的 9例妇女 ,采用选择性插管至输卵管开口处 ,推注 30 %泛影葡胺造影剂 ,对证实阻塞者行导丝再通 ,其中 4 3例再通术后 ,中西药治疗 1～ 4个月 ;4 0例对照组插管再通术后单服抗生素治疗 4～ 6天 ,术后均随访 1～ 4个月 ,6例未随访 ,观察两组受孕率 .结果　插管成功率 10 0 % ,无严重并发症 ,复通率 80 % ,再通术后未行中药治疗组妊娠率 2 7.5 % ( 11/ 4 0 ) ,再通术后中西药治疗组妊娠率 6 0 % ( 2 6 / 4 3) .结论　选择性输卵管造影与插管再通术 ,术后配合活血化瘀 ,消炎解毒的中西药治疗是目前治疗输卵管近、中段阻塞性不孕的最好方法 .     

壳聚糖防止输卵管阻塞介入再通术后的复发性黏连

目的 评价壳聚糖(几丁糖)在输卵管介入再通术后防止复发性黏连的疗效.方法 309例患者随机分为对照组206例和试验组103例.对照组在输卵管阻塞介入复通术中常规注射松解液(α-糜蛋白酶、地塞米松、灭滴灵、庆大霉素)做术后防止黏连.试验组在术中常规注射松解液的基础上联合应用医用几丁糖防止黏连,术后通水治疗.随访观察两组病例松解输卵管的通畅情况.结果 试验组,经子宫输卵管碘水造影阻塞190条,缺如10条;介入复通188条,再通率为98.9%;术后随访3个月通水达到无阻力180条,再黏连率4.26%(8/188).对照组输卵管造影确认堵塞390条,缺如22条,复通385条,复通率为98.7%,术后随访3个月,通水达到无阻力330条,再黏连率14.28%(55/385).两组术后3个月再黏连率有差异(P＜0.01).结论 输卵管介入再通术后应用几丁糖能有效降低输卵管术后复发性黏连.     

壳聚糖防止输卵管阻塞介入再通术后的复发性黏连

目的评价壳聚糖(几丁糖)在输卵管介入再通术后防止复发性黏连的疗效。方法309例患者随机分为对照组206例和试验组103例。对照组在输卵管阻塞介入复通术中常规注射松解液(α-糜蛋白酶?地塞米松、灭滴灵?庆大霉素)做术后防止黏连。试验组在术中常规注射松解液的基础上联合应用医用几丁糖防止黏连,术后通水治疗。随访观察两组病例松解输卵管的通畅情况。结果试验组,经子宫输卵管碘水造影阻塞190条,缺如10条;介入复通188条,再通率为98.9%;术后随访3个月通水达到无阻力180条,再黏连率4.26%(8/188)。对照组输卵管造影确认堵塞390条,缺如22条,复通385条,复通率为98.7%,术后随访3个月,通水达到无阻力330条,再黏连率14.28%(55/385)。两组术后3个月再黏连率有差异(P<0.01)。结论输卵管介入再通术后应用几丁糖能有效降低输卵管术后复发性黏连。     

介入术输卵管再通临床应用体会

目的回顾122例已婚不孕妇女行介入术输卵管再通后的临床疗效分析,评价其在治疗输卵管阻塞所致不孕症的应用价值。方法122例不孕症患者均在X线床上取截石位,在电视透视下将导管送入阻塞部位,经造影后行再通治疗,以造影剂进入盆腔证明阻塞段再通。结果122例220条不通输卵管中,行再通术后175条通畅度明显改善,盆腔内造影剂弥散总有效率为79.5%,经再通术后八个月随访观察,有39例发生妊娠,妊娠率占30.5%.因术后不孕复查发生再粘连者31例,占17.7%,其中结核5例10条,伞部重度积水8条.结论选择性输卵管造影再通术是目前诊断和治疗输卵管阻塞所致不孕症最简便、安全、无创伤,经济有效的方法。     

选择性输卵管造影与再通术诊治阻塞性不孕(100例报告)

目的:评价输卵管插管造影及再通术对输卵管阻塞性不孕的诊治价值.材料与方法:先经宫颈对常规子宫、输卵管造影(HSG)显示输卵管阻塞的100例不孕妇女的180条输卵管进行插管,采用选择性插管至输卵管开口处推注30%泛影葡胺造影,对证实阻塞者进行导丝再通,术后随访2～4个月 结果:插管成功率100%.无严重并发症,复通率80%,妊娠系21%(21/100)结论:选择性输卵管造影及再通术是目前诊治阻塞性不孕的最好方法     

输卵管介入再通术灌注药物研究

输卵管阻塞性不孕症发病率高,占女性不孕症30%～50%,且有逐年上升的趋势.采用介入方法对输卵管阻塞进行再通和直接对输卵管腔内灌注药物治疗已取得较好的疗效,输卵管介入再通率可达71～92%,受孕率大概为30%[1].大量临床研究表明,术后再粘连是影响介入再通术疗效的关键因素.因此,在解决输卵管梗阻的同时,如何促进炎症吸收和减少术后再粘连,如何选择和规范输卵管腔内灌注药物成为研究的热点之一.     

宫腹腔镜下输卵管插管及斑马导丝疏通术治疗输卵管阻塞

目的 探讨宫、腹腔镜联合行输卵管插管及斑马导丝疏通术治疗输卵管阻塞性不孕症的临床意义.方法 收集腹腔镜染色通液证实输卵管阻塞的不孕患者83例,共103条输卵管阻塞,行宫腔镜联合腹腔镜下行输卵管插管及斑马导丝疏通术,观察输卵管通畅情况及有无并发症,追踪术后妊娠情况.结果 103条阻塞输卵管,88条疏通成功,以选择性输卵管插管加压通液术成功疏通57条(55.3%),失败46条(44.7%),46条中再以斑马导丝疏通成功31条(67.4%,31/46),总通畅率为85.4% (88:103).15条输卵管斑马导丝疏通失败.术后全部病例随访1～20个月,中位随访时间8个月,21例(25.3%)妊娠:宫内妊娠19例(22.9%),2例自然流产(2.4%),2例输卵管妊娠(2.4%).1条输卵管假道形成,发生率1.0%(1:103).结论 本文结果提示宫腹腔镜联合行输卵管插管及斑马导丝疏通术治疗输卵管阻塞性不孕症安全有效,值得深入研究.     

输卵管阻塞性不孕症介人治疗26例分析

输卵管阻塞是不孕症最常见的病因,约占不孕病因的1/3.本文对26例输卵管阻塞性不孕症采用介入放射学的选择性输卵管造影和再通术,对26例52条输卵管,缺如2条,Ⅰ类梗阻6条,Ⅱ类24条,Ⅲ类9条,Ⅳ类4条,V类7条.SSG43条复通22条,FTR21条复通17条,失败4条.SSG+FTR复通成功率为90.7%.至今已有9例妊娠.采用此介入治疗,提高了诊断和再通的成功率,临床上有其独特的治疗价值.     

Adenocarcinoma of the fallopian tube

Summary A case of fallopian tube adenocarcinoma was studied by light and transmission electron microscopy. The neoplastic cells contained abundant mitochondria, moderate to large amounts of rough endoplasmic reticulum (RER) arranged in parallel arrays and often containing amorphous material, annulate lamellae, possible secretory vesicles, and glycogen. The presence of stacked RER and annulate lamellae together is unusual in papillary serous cystadenocarcinoma of the ovary, and has not been described in Fallopian tube adenocarcinoma. Golgi complexes were are. Small acini with projecting microvilli as well as junctional complexes were present, but cilia were not found. The electron microscopic findings suggest secretory activity, and are remarkably similar to those found in papillary serous cystadenocarcinomas of the ovary. The findings also support the hypothesis that ovarian serous tumors and adenocarcinomas of the Fallopian tube are derived from coelomic epithelium.     

Polyp of the fallopian tube

The case of a 34-year-old woman who had a radical hysterectomy for stage 1 b squamous cell carcinoma of the cervix and in whom an epithelial polyp was identified in the left fallopian tube is presented. The case is unusual in that the polyp developed in the absence of any evidence of tubal damage as demonstrated by a history of endometriosis or tubal sterilisation.     

Extraskeletal chondroma of the fallopian tube

Extraskeletal chondroma can occur in the hands, feet, head and neck. This tumor usually presents as a small solitary nodule. The histogenesis of the tumor is controversial, but some have suggested a metaplastic origin. Chondroma of the fallopian tube is very rare. There is only one report in English literature. The origin of this tumor can be subcoelomic mesenchyme of the tubal serosa or mesenchyme of the myosalpinx. We describe a case of chondroma arising from the serosal surface of the fallopian tube with a review of literature. A 30-yr-old woman visited hospital due to left adnexal mass. On operating finding, 2 x 3 cm sized nodular mass was noted on the left tubal serosal area. The excised mass showed multilobulated appearance covered with thin fibrous membrane. The cut surface was solid, grayish yellow, and myxoid with a focal gelatinous area. The microscopic finding showed islands and elongated lobules of mature benign cartilage without cytologic atypia.     

Xanthelasma or xanthoma of the fallopian tube

We report a case of a 24-year-old woman who presented with abdominal pain, a tense abdomen, and rebound tenderness. A vague, ill-defined mass was palpated, and an ultrasound examination revealed a cystic lesion in the left adnexal region. At laparotomy, a slightly dilated fallopian tube was seen and excised. Light microscopy showed intact fallopian tube mucosa, with a diffuse infiltrate of foam cells in the lamina propria. There were no associated inflammatory cells. The foam cells were positive for CD68 and negative for AE1/AE3. Discontinuous areas of the epithelium also showed epithelial cells with "foamy cytoplasm." These cells were negative for CD68 but positive for AE1/AE3. To our knowledge, this represents the first case of a fallopian tube xanthelasma that shows a resemblance to lesions encountered in the stomach. Fallopian tube xanthelasma must be distinguished from xanthogranulomatous salpingitis, which is associated with an inflammatory cell infiltrate, often including giant cells. However, this lesion may share pathogenetic similarities with xanthogranulomatous salpingitis, since both processes are mediated by inflammation.     

Heterotopic mesodermal tumor of the fallopian tube

An observation of heterologous mesodermal tumor of the fallopian tube in a woman of 53 is described. The tumor had the structure of adenoacanthocarcinosarcoma with inclusions of atypical cartilage. The patient died 6 months after the operation from generalized process. The rare localization of this tumor is noted.